<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(1)</volume><submitter>Mahdy AKH</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Inflammatory bowel disease (IBD) is an incurable immune-mediated inflammatory disease, affecting the gut with a high rate of primary- and secondary- loss-of-response to therapy. By investigating the T cell receptor repertoire of individuals with IBD, novel therapeutic and preventive strategies can be identified, and a better understanding of IBD can be obtained.&lt;h4>Methods&lt;/h4>To identify and validate T cell clonotypes implicated in the pathogenesis of IBD, we profiled the T cell receptor alpha (TRA) repertoire of three cohorts containing treatment-naive, treated individuals, and individuals living with the disease for >20 years, resulting in an exhaustive dataset containing the TRA repertoire of 1,732 individuals.&lt;h4>Results&lt;/h4>Using the generated datasets, we were abl</pubmed_abstract><journal>Genome medicine</journal><pagination>3</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12784487</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with inflammatory bowel disease across different disease stages.</pubmed_title><pmcid>PMC12784487</pmcid><pubmed_authors>Pesesky M</pubmed_authors><pubmed_authors>Robins HS</pubmed_authors><pubmed_authors>Kriukova V</pubmed_authors><pubmed_authors>Moum B</pubmed_authors><pubmed_authors>Howie B</pubmed_authors><pubmed_authors>Franke A</pubmed_authors><pubmed_authors>Mahdy AKH</pubmed_authors><pubmed_authors>May DH</pubmed_authors><pubmed_authors>Andersen S</pubmed_authors><pubmed_authors>Jahnsen J</pubmed_authors><pubmed_authors>Schreiber S</pubmed_authors><pubmed_authors>Olbjorn C</pubmed_authors><pubmed_authors>IBSEN-III study group</pubmed_authors><pubmed_authors>ElAbd H</pubmed_authors><pubmed_authors>Detlie TE</pubmed_authors><pubmed_authors>Vatn MH</pubmed_authors><pubmed_authors>Perminow G</pubmed_authors><pubmed_authors>Hoivik ML</pubmed_authors><pubmed_authors>Bokemeyer B</pubmed_authors><pubmed_authors>Bengtson MB</pubmed_authors><pubmed_authors>Kristensen VA</pubmed_authors><pubmed_authors>Kokubun EE</pubmed_authors><pubmed_authors>Hov JR</pubmed_authors><pubmed_authors>Ricanek P</pubmed_authors><pubmed_authors>Halfvarson J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with inflammatory bowel disease across different disease stages.</name><description>&lt;h4>Background&lt;/h4>Inflammatory bowel disease (IBD) is an incurable immune-mediated inflammatory disease, affecting the gut with a high rate of primary- and secondary- loss-of-response to therapy. By investigating the T cell receptor repertoire of individuals with IBD, novel therapeutic and preventive strategies can be identified, and a better understanding of IBD can be obtained.&lt;h4>Methods&lt;/h4>To identify and validate T cell clonotypes implicated in the pathogenesis of IBD, we profiled the T cell receptor alpha (TRA) repertoire of three cohorts containing treatment-naive, treated individuals, and individuals living with the disease for >20 years, resulting in an exhaustive dataset containing the TRA repertoire of 1,732 individuals.&lt;h4>Results&lt;/h4>Using the generated datasets, we were abl</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-06T11:50:53.658Z</modification><creation>2026-05-30T03:09:11.398Z</creation></dates><accession>S-EPMC12784487</accession><cross_references><pubmed>41514338</pubmed><doi>10.1186/s13073-025-01575-w</doi></cross_references></HashMap>